Gsk GSK
NYSE GSK
$50.13 +1.99 (+4.15%)
As of: Sep 14, 2026 · 2:16 PM EDT

Gsk (GSK) Finished Goods (2013 - 2014)

Gsk (GSK) posted Finished Goods of $2.3 billion for Q4 2014, down 4.86% quarter-over-quarter from $2.4 billion in Q4 2013, and down 4.86% YoY from $2.4 billion in Q4 2013.

Analysis

Gsk (GSK) Finished Goods (2013 - 2014) Analysis & Trends

Gsk (GSK) has 2 years of Finished Goods data on file, last reported at $2.3 billion in Q4 2014.

  • For the quarter ending Q4 2014, Finished Goods fell 4.86% year-over-year to $2.3 billion; the trailing twelve-month figure through Dec 2014 stood at $2.3 billion (down 4.86% YoY), and the FY2014 full-year result was $2.3 billion, down 4.86% from the prior year.
  • Finished Goods was $2.3 billion for Q4 2014 at Gsk, down from $2.4 billion in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $2.4 billion in Q4 2013 to a low of $2.3 billion in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.86 Bn 602.88 Bn 5.90 Bn
2 Hsbc Holdings 361.40 Bn 361.40 Bn -
3 General Electric 329.38 Bn 320.03 Bn 6.95 Bn
4 Astrazeneca 253.73 Bn 248.44 Bn 12.86 Bn
5 Citigroup 228.07 Bn -2,074.24 Bn 24.75 Bn
6 Bhp 216.09 Bn 197.55 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.36 Bn 195.32 Bn -
9 Unilever 139.15 Bn 132.12 Bn -
10 Gsk 101.53 Bn 101.53 Bn 15.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 2.33 Bn
Dec 31, 2013 2.45 Bn